← FDA Drug Approvals (Drugs@FDA)

VALSARTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2021-10-27

Drug application

FDA Application #

ANDA204038

Application type

Abbreviated New Drug Application (Generic)

Brand name

VALSARTAN

Generic name

VALSARTAN

Active ingredients

VALSARTAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

Manufacturer

ScieGen Pharmaceuticals, INC.

First approval

2021-10-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown